• Profile
Close

Predicting the value of adjuvant therapy in esophageal squamous cell carcinoma by combining the total number of examined lymph nodes with the positive lymph node ratio

Annals of Surgical Oncology Jul 13, 2019

Li Y, et al. - Researchers assessed if parameters connected to lymph node (LN) status can predict the value of adjuvant therapy in esophageal squamous cell carcinoma (ESCC). Reception of adjuvant chemotherapy, radiotherapy, or chemoradiotherapy defined adjuvant therapy. Among 298 patients with ESCC who had undergone radical esophagectomy with lymphadenectomy, total number of resected LNs (TLNs), LN ratio (LNR), and pN stage were identified to be the independent prognostic factors for survival. The value of adjuvant therapy could be predicted by combining TLNs and LNR in contrast to using TLNs, LNR, and pN stage individually.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay